Guided blood thinner choice after minor stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether adjusting blood-thinner medication based on a blood test can better prevent another stroke in people who recently had a minor stroke or a high-risk mini-stroke. It aims to find the safest and most effective dose for each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a minor stroke or a high-risk mini-stroke within the last 48 hours.
- You can start taking clopidogrel and aspirin within 48 hours of your symptoms.
- Your blood test shows a certain level of platelet activity after starting these medicines.
- You are willing to take either aspirin plus clopidogrel or clopidogrel alone.
- You do not have conditions like bleeding disorders, heart rhythm problems, or recent major bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests can predict if the antiplatelet drug clopidogrel (Plavix) will work well in people who have had a mild stroke or a mini-stroke (TIA). The goal is to help doctors choose the best treatment for each person.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This study compares two ways to treat a minor stroke: taking two blood-thinning pills (aspirin and clopidogrel) versus receiving a clot-busting medicine (alteplase) through an IV. The goal is to see which approach works better and has fewer side effects.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
This trial tests whether switching to a simpler antiplatelet medication (ticagrelor) after a mild stroke or high-risk TIA can prevent another stroke while reducing the risk of bleeding. It is for people who have not received clot-busting treatment or had a large stroke.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.